This is a preview of subscription content, log in via an institution to check access.
Notes
Institute for Quality and Efficiency in Health Care
Reference
German Institute for Quality and Efficiency in Health Care. Aflibercept in AMD: no proof of added benefit. Media Release : 15 Mar 2013. Available from: URL: http://www.iqwig.de
Rights and permissions
About this article
Cite this article
Aflibercept no added benefit in AMD, says IQWiG. PharmacoEcon Outcomes News 675, 11 (2013). https://doi.org/10.1007/s40274-013-0297-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0297-6